Head-to-head dispatch
Aspen vs Zealthy
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Aspen (Aspen Health Systems LLC) is a LegitScript-certified telehealth clinic offering compounded semaglutide and tirzepatide as physician-chosen weekly injections, with flat pricing at every dose.
Marked down on: Compounded semaglutide and tirzepatide only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
Desk Score
Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.
Marked down on: Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.
Aspen takes this head-to-head with the higher Desk Score, 78/100 (C+) against 51/100 (C) for Zealthy. Zealthy still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Aspen
78/100
C+
Zealthy
51/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Aspen | Zealthy |
|---|---|---|
| Semaglutide | $279/mo (3-month plan, compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $399/mo (compounded) | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | All 50 states | 34 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want legitScript-certified compounded semaglutide/tirzepatide with a named accredited pharmacy and flat dosing. | Readers who want not currently recommended — listed for transparency and reader awareness only. |
| Desk Score | 78/100C+ | 51/100C |
The verdict
Desk pick — AspenAspen takes this head-to-head with the higher Desk Score, 78/100 (C+) against 51/100 (C) for Zealthy. Zealthy still holds its ground where its strengths line up with yours.
Choose Aspen if…
Readers who want legitScript-certified compounded semaglutide/tirzepatide with a named accredited pharmacy and flat dosing.
$279/mo (3-month plan, compounded) sema · $399/mo (compounded) tirz · All 50 states
Choose Zealthy if…
Readers who want not currently recommended — listed for transparency and reader awareness only.
$286/mo (starting dose, plus a separate fee, compounded) sema · $351/mo (starting dose, plus a separate fee, compounded) tirz · 34 states
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Aspen · Zealthy.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Aspen vs CoreAge Rx
- Zealthy vs Vaylen
- Aspen vs Strut Health
- Zealthy vs Ondra Health
- Aspen vs Invigor Medical
- Zealthy vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.